Register entry

Zealand Pharma A/S

Data as of · How to read this entry

Registered sites
2
Active NDC listings
0
Live patents
4
Exclusivities
2
Countries
2
Base
Denmark
Authorisation

Registered operations

Labelling1Finished drug manufacture1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Zealand Pharma A/SSydmarken 11, Soeborg, 2860, Denmark (DNK)Finished drug manufacture3016672909586358020
Zealand Pharma US, Inc.Registrant: Zealand Pharma A/S50 Milk St Fl 16, Boston, Massachusetts (MA) 02109-5002, United States (USA)Labelling3032326177119319862
Exclusivity

Patents and exclusivities

4
PatentProductCoversExpiry
11795204ZEGALOGUE, ZEGALOGUE (AUTOINJECTOR)dasiglucagon hydrochlorideuseJan 2034
10442847ZEGALOGUE, ZEGALOGUE (AUTOINJECTOR)dasiglucagon hydrochloridesubstance, productMar 2035
ProductExclusivityUntil
ZEGALOGUEDASIGLUCAGON HYDROCHLORIDENPP New patient populationJun 2029
ZEGALOGUE (AUTOINJECTOR)DASIGLUCAGON HYDROCHLORIDENPP New patient populationJun 2029
Neighbours

Registered in the same town

7
Compare

Comparable companies in Denmark

Enquiry

Common questions

Is Zealand Pharma A/S FDA approved?
Zealand Pharma A/S holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Zealand Pharma A/S's drugs manufactured?
At registered sites in Denmark, the United States. The FDA register lists Soeborg; Boston, MA. Registered operations: labelling, finished drug manufacture.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.